{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:10:59Z","timestamp":1790644259917,"version":"4.1.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1097\/md.0000000000006770","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T15:54:01Z","timestamp":1493135641000},"page":"e6770","source":"Crossref","is-referenced-by-count":52,"title":["Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy"],"prefix":"10.1097","volume":"96","author":[{"given":"Jose Luis","family":"Martin-Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Gonzalez-Cantero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Gonzalez-Cantero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pedro","family":"Arrebola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Luis","family":"Gonzalez-Calvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-59-20210226","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"key":"R2-59-20210226","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"key":"R3-59-20210226","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jhep.2007.02.007","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center","volume":"47","author":"Lee","year":"2007","journal-title":"J Hepatol"},{"key":"R4-59-20210226","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"R5-59-20210226","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R6-59-20210226","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"R7-59-20210226","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"R8-59-20210226","first-page":"234","article-title":"Long-term follow-up of patients with nonalcoholic fatty liver","volume":"7","author":"Rafiq","year":"2009","journal-title":"YJCGH"},{"key":"R9-59-20210226","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1572-0241.2003.07486.x","article-title":"The prevalence and etiology of elevated aminotransferase levels in the United States","volume":"98","author":"Clark","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R10-59-20210226","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1478-3231.2008.01718.x","article-title":"Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus","volume":"29","author":"Leite","year":"2009","journal-title":"Liver Int"},{"key":"R11-59-20210226","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"R12-59-20210226","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"R13-59-20210226","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/hep.27395","article-title":"The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease","volume":"61","author":"Maximos","year":"2015","journal-title":"Hepatology"},{"key":"R14-59-20210226","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"key":"R15-59-20210226","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/01.mcg.0000225668.53673.e6","article-title":"Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment","volume":"40","author":"Goland","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"R16-59-20210226","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1161\/ATVBAHA.111.234062","article-title":"Fatty liver, abdominal visceral fat, and cardiometabolic risk factors: the Jackson Heart Study","volume":"31","author":"Liu","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R17-59-20210226","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1053\/j.gastro.2008.09.018","article-title":"Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease","volume":"135","author":"Goessling","year":"2008","journal-title":"Gastroenterology"},{"key":"R18-59-20210226","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1210\/jc.2015-1966","article-title":"High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels","volume":"100","author":"Portillo Sanchez","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-59-20210226","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.2337\/diabetes.51.6.1889","article-title":"High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes","volume":"51","author":"Vozarova","year":"2002","journal-title":"Diabetes"},{"key":"R20-59-20210226","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.atherosclerosis.2006.04.006","article-title":"Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study","volume":"191","author":"Schindhelm","year":"2007","journal-title":"Atherosclerosis"},{"key":"R21-59-20210226","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2008.11.005","article-title":"Implications of elevated serum alanine aminotransferase levels: think outside the liver","volume":"135","author":"Ioannou","year":"2008","journal-title":"Gastroenterology"},{"key":"R22-59-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels","volume":"137","author":"Prati","year":"2002","journal-title":"Ann Intern Med"},{"key":"R23-59-20210226","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/hep.20818","article-title":"Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women","volume":"42","author":"Kunde","year":"2005","journal-title":"Hepatology"},{"key":"R24-59-20210226","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1440-1746.2010.06481.x","article-title":"Healthy range for serum ALT and the clinical significance of \u201cunhealthy\u201d normal ALT levels in the Korean population","volume":"26","author":"Kang","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"R25-59-20210226","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2036.2012.05224.x","article-title":"Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34,346 subjects","volume":"36","author":"Wu","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R26-59-20210226","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00535-012-0534-y","article-title":"Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study","volume":"47","author":"Miyake","year":"2012","journal-title":"J Gastroenterol"},{"key":"R27-59-20210226","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","article-title":"Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population","volume":"288","author":"Szczepaniak","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R28-59-20210226","first-page":"1","article-title":"Quantitative assessment of liver fat with magnetic resonance","volume":"34","author":"Reeder","year":"2012","journal-title":"J Magn Reson Imaging"},{"key":"R29-59-20210226","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2009.05.023","article-title":"Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance","volume":"51","author":"Schwenzer","year":"2009","journal-title":"J Hepatol"},{"key":"R30-59-20210226","first-page":"E977","article-title":"Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo","volume":"276","author":"Szczepaniak","year":"1999","journal-title":"Am J Physiol"},{"key":"R31-59-20210226","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","article-title":"Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study","volume":"51","author":"Dasarathy","year":"2009","journal-title":"J Hepatol"},{"key":"R32-59-20210226","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/MEG.0b013e3283650650","article-title":"Sonographic quantification of a Hepato-Renal Index for the assessment of hepatic steatosis in comparison with 3T proton magnetic resonance spectroscopy","volume":"26","author":"Mart\u00edn-Rodr\u00edguez","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R33-59-20210226","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"R34-59-20210226","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jhep.2010.04.018","article-title":"In vivo 3T spectroscopic quantification of liver fat content in nonalcoholic fatty liver disease: Correlation with biochemical method and morphometry","volume":"53","author":"Roldan-Valadez","year":"2010","journal-title":"J Hepatol"},{"key":"R35-59-20210226","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.mri.2011.07.028","article-title":"Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model","volume":"30","author":"Van Werven","year":"2012","journal-title":"Magn Reson Imaging"},{"key":"R36-59-20210226","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00330-010-1905-5","article-title":"The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis","volume":"21","author":"Bohte","year":"2011","journal-title":"Eur Radiol"},{"key":"R37-59-20210226","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/hep.26455","article-title":"Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials","volume":"58","author":"Noureddin","year":"2013","journal-title":"Hepatology"},{"key":"R38-59-20210226","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jash.2014.03.002","article-title":"Adiponectin is better predictor of subclinical atherosclerosis than liver function tests in patients with nonalcoholic fatty liver disease","volume":"8","author":"Omelchenko","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"R39-59-20210226","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/1753-0407.12221","article-title":"Alanine transferase: an independent indicator of adiposity related comorbidity risk in youth","volume":"7","author":"Klein","year":"2015","journal-title":"J Diabetes"},{"key":"R40-59-20210226","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.cgh.2015.01.027","article-title":"Association between quantity of liver fat and cardiovascular risk in patients with nonalcoholic fatty liver disease independent of nonalcoholic steatohepatitis","volume":"13","author":"Arulanandan","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R41-59-20210226","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.2337\/diacare.28.12.2913","article-title":"Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men","volume":"28","author":"Wannamethee","year":"2005","journal-title":"Diabetes Care"},{"key":"R42-59-20210226","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.arcmed.2013.04.001","article-title":"Relationship between visceral adipose tissue and adiponectin, inflammatory markers and thyroid hormones in obese males with hepatosteatosis and insulin resistance","volume":"44","author":"Ozcelik","year":"2013","journal-title":"Arch Med Res"},{"key":"R43-59-20210226","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1210\/jc.2004-0077","article-title":"Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis","volume":"89","author":"Gonzalez-Calvin","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R44-59-20210226","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1210\/jc.2009-0835","article-title":"Bone mineral density and serum levels of soluble tumor necrosis factors, estradiol, and osteoprotegerin in postmenopausal women with cirrhosis after viral hepatitis","volume":"94","author":"Gonz\u00e1lez-Calvin","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R45-59-20210226","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.20280","article-title":"Beyond insulin resistance in NASH: TNF-\u03b1 or adiponectin?","volume":"40","author":"Hui","year":"2004","journal-title":"Hepatology"},{"key":"R46-59-20210226","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2337\/diabetes.47.11.1757","article-title":"Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance","volume":"47","author":"Fern\u00e1ndez-Real","year":"1998","journal-title":"Diabetes"},{"key":"R47-59-20210226","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2001.25540","article-title":"Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese","volume":"121","author":"Dixon","year":"2001","journal-title":"Gastroenterology"},{"key":"R48-59-20210226","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1539\/joh.46.423","article-title":"Efficacy and effectiveness of liver screening program to detect fatty liver in the periodic health check-ups","volume":"46","author":"Nomura","year":"2004","journal-title":"J Occup Health"},{"key":"R49-59-20210226","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000006770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:48:46Z","timestamp":1620960526000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201704280-00059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":49,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000006770","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}